nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—MMP2—pancreatic cancer	0.346	0.603	CbGaD
Captopril—MMP9—pancreatic cancer	0.227	0.397	CbGaD
Captopril—ALB—Erlotinib—pancreatic cancer	0.0238	0.139	CbGbCtD
Captopril—ALB—Irinotecan—pancreatic cancer	0.0215	0.126	CbGbCtD
Captopril—ALB—Fluorouracil—pancreatic cancer	0.0206	0.121	CbGbCtD
Captopril—F2—hepatic artery—pancreatic cancer	0.0154	0.271	CbGeAlD
Captopril—ABCB1—Tamoxifen—pancreatic cancer	0.0146	0.0857	CbGbCtD
Captopril—CYP2D6—Tamoxifen—pancreatic cancer	0.0138	0.0808	CbGbCtD
Captopril—F2—portal vein—pancreatic cancer	0.0134	0.236	CbGeAlD
Captopril—ABCB1—Gemcitabine—pancreatic cancer	0.0126	0.0739	CbGbCtD
Captopril—ABCB1—Erlotinib—pancreatic cancer	0.0124	0.0729	CbGbCtD
Captopril—CYP2D6—Erlotinib—pancreatic cancer	0.0117	0.0687	CbGbCtD
Captopril—ABCB1—Irinotecan—pancreatic cancer	0.0112	0.0658	CbGbCtD
Captopril—ABCB1—Docetaxel—pancreatic cancer	0.00823	0.0482	CbGbCtD
Captopril—ABCB1—Sunitinib—pancreatic cancer	0.00819	0.048	CbGbCtD
Captopril—ABCB1—Doxorubicin—pancreatic cancer	0.00613	0.036	CbGbCtD
Captopril—CYP2D6—Doxorubicin—pancreatic cancer	0.00578	0.0339	CbGbCtD
Captopril—ACE—umbilical vein—pancreatic cancer	0.00341	0.0601	CbGeAlD
Captopril—MMP2—gall bladder—pancreatic cancer	0.00303	0.0533	CbGeAlD
Captopril—LTA4H—islet of Langerhans—pancreatic cancer	0.0028	0.0493	CbGeAlD
Captopril—F2—gall bladder—pancreatic cancer	0.0023	0.0405	CbGeAlD
Captopril—MMP2—islet of Langerhans—pancreatic cancer	0.00198	0.035	CbGeAlD
Captopril—LTA4H—pancreas—pancreatic cancer	0.00197	0.0346	CbGeAlD
Captopril—LTA4H—digestive system—pancreatic cancer	0.00168	0.0296	CbGeAlD
Captopril—ALB—gall bladder—pancreatic cancer	0.00147	0.0258	CbGeAlD
Captopril—MMP2—pancreas—pancreatic cancer	0.00139	0.0246	CbGeAlD
Captopril—REN—digestive system—pancreatic cancer	0.0013	0.0228	CbGeAlD
Captopril—MMP9—pancreas—pancreatic cancer	0.00121	0.0214	CbGeAlD
Captopril—MMP2—digestive system—pancreatic cancer	0.00119	0.021	CbGeAlD
Captopril—MMP9—digestive system—pancreatic cancer	0.00104	0.0183	CbGeAlD
Captopril—F2—digestive system—pancreatic cancer	0.000904	0.0159	CbGeAlD
Captopril—SLC15A1—digestive system—pancreatic cancer	0.00077	0.0136	CbGeAlD
Captopril—ACE—digestive system—pancreatic cancer	0.000552	0.00973	CbGeAlD
Captopril—ABCB1—islet of Langerhans—pancreatic cancer	0.000324	0.0057	CbGeAlD
Captopril—CYP2D6—digestive system—pancreatic cancer	0.00027	0.00476	CbGeAlD
Captopril—ABCB1—pancreas—pancreatic cancer	0.000228	0.00401	CbGeAlD
Captopril—ABCB1—digestive system—pancreatic cancer	0.000194	0.00342	CbGeAlD
Captopril—Paraesthesia—Irinotecan—pancreatic cancer	0.000119	0.00108	CcSEcCtD
Captopril—Cerebrovascular accident—Doxorubicin—pancreatic cancer	0.000119	0.00108	CcSEcCtD
Captopril—Hypotension—Fluorouracil—pancreatic cancer	0.000119	0.00108	CcSEcCtD
Captopril—Rash—Tamoxifen—pancreatic cancer	0.000119	0.00108	CcSEcCtD
Captopril—Dermatitis—Tamoxifen—pancreatic cancer	0.000119	0.00108	CcSEcCtD
Captopril—Ataxia—Epirubicin—pancreatic cancer	0.000119	0.00108	CcSEcCtD
Captopril—Vomiting—Erlotinib—pancreatic cancer	0.000119	0.00108	CcSEcCtD
Captopril—Dyspnoea—Irinotecan—pancreatic cancer	0.000119	0.00108	CcSEcCtD
Captopril—Somnolence—Irinotecan—pancreatic cancer	0.000118	0.00107	CcSEcCtD
Captopril—Headache—Tamoxifen—pancreatic cancer	0.000118	0.00107	CcSEcCtD
Captopril—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000118	0.00107	CcSEcCtD
Captopril—Rash—Erlotinib—pancreatic cancer	0.000118	0.00107	CcSEcCtD
Captopril—Dermatitis—Erlotinib—pancreatic cancer	0.000117	0.00107	CcSEcCtD
Captopril—Hyponatraemia—Doxorubicin—pancreatic cancer	0.000117	0.00106	CcSEcCtD
Captopril—Insomnia—Gemcitabine—pancreatic cancer	0.000117	0.00106	CcSEcCtD
Captopril—Dyspepsia—Irinotecan—pancreatic cancer	0.000117	0.00106	CcSEcCtD
Captopril—Headache—Erlotinib—pancreatic cancer	0.000117	0.00106	CcSEcCtD
Captopril—Paraesthesia—Gemcitabine—pancreatic cancer	0.000116	0.00106	CcSEcCtD
Captopril—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000116	0.00105	CcSEcCtD
Captopril—Asthenia—Sunitinib—pancreatic cancer	0.000116	0.00105	CcSEcCtD
Captopril—Decreased appetite—Irinotecan—pancreatic cancer	0.000116	0.00105	CcSEcCtD
Captopril—Dyspnoea—Gemcitabine—pancreatic cancer	0.000115	0.00105	CcSEcCtD
Captopril—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.000115	0.00105	CcSEcCtD
Captopril—Insomnia—Fluorouracil—pancreatic cancer	0.000115	0.00105	CcSEcCtD
Captopril—Somnolence—Gemcitabine—pancreatic cancer	0.000115	0.00105	CcSEcCtD
Captopril—Fatigue—Irinotecan—pancreatic cancer	0.000115	0.00104	CcSEcCtD
Captopril—Paraesthesia—Fluorouracil—pancreatic cancer	0.000114	0.00104	CcSEcCtD
Captopril—Alopecia—Docetaxel—pancreatic cancer	0.000114	0.00104	CcSEcCtD
Captopril—Pruritus—Sunitinib—pancreatic cancer	0.000114	0.00104	CcSEcCtD
Captopril—Constipation—Irinotecan—pancreatic cancer	0.000114	0.00103	CcSEcCtD
Captopril—Dyspnoea—Fluorouracil—pancreatic cancer	0.000114	0.00103	CcSEcCtD
Captopril—Somnolence—Fluorouracil—pancreatic cancer	0.000113	0.00103	CcSEcCtD
Captopril—Decreased appetite—Gemcitabine—pancreatic cancer	0.000113	0.00102	CcSEcCtD
Captopril—Dyspepsia—Fluorouracil—pancreatic cancer	0.000112	0.00102	CcSEcCtD
Captopril—Nausea—Tamoxifen—pancreatic cancer	0.000112	0.00102	CcSEcCtD
Captopril—Fatigue—Gemcitabine—pancreatic cancer	0.000112	0.00101	CcSEcCtD
Captopril—Muscular weakness—Epirubicin—pancreatic cancer	0.000111	0.00101	CcSEcCtD
Captopril—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000111	0.00101	CcSEcCtD
Captopril—Constipation—Gemcitabine—pancreatic cancer	0.000111	0.00101	CcSEcCtD
Captopril—Nausea—Erlotinib—pancreatic cancer	0.000111	0.00101	CcSEcCtD
Captopril—Decreased appetite—Fluorouracil—pancreatic cancer	0.000111	0.00101	CcSEcCtD
Captopril—Diarrhoea—Sunitinib—pancreatic cancer	0.00011	0.001	CcSEcCtD
Captopril—Dysgeusia—Docetaxel—pancreatic cancer	0.00011	0.001	CcSEcCtD
Captopril—Ataxia—Doxorubicin—pancreatic cancer	0.00011	0.000997	CcSEcCtD
Captopril—Feeling abnormal—Irinotecan—pancreatic cancer	0.00011	0.000995	CcSEcCtD
Captopril—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000109	0.000987	CcSEcCtD
Captopril—Eosinophilia—Epirubicin—pancreatic cancer	0.000108	0.00098	CcSEcCtD
Captopril—Pancreatitis—Epirubicin—pancreatic cancer	0.000107	0.000971	CcSEcCtD
Captopril—Dizziness—Sunitinib—pancreatic cancer	0.000107	0.000969	CcSEcCtD
Captopril—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000107	0.000969	CcSEcCtD
Captopril—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000107	0.000968	CcSEcCtD
Captopril—Angina pectoris—Epirubicin—pancreatic cancer	0.000106	0.000964	CcSEcCtD
Captopril—Body temperature increased—Irinotecan—pancreatic cancer	0.000105	0.000955	CcSEcCtD
Captopril—Abdominal pain—Irinotecan—pancreatic cancer	0.000105	0.000955	CcSEcCtD
Captopril—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000105	0.000953	CcSEcCtD
Captopril—Anaemia—Docetaxel—pancreatic cancer	0.000104	0.000945	CcSEcCtD
Captopril—Pancytopenia—Epirubicin—pancreatic cancer	0.000104	0.00094	CcSEcCtD
Captopril—Muscular weakness—Doxorubicin—pancreatic cancer	0.000103	0.000935	CcSEcCtD
Captopril—Vomiting—Sunitinib—pancreatic cancer	0.000103	0.000932	CcSEcCtD
Captopril—Body temperature increased—Gemcitabine—pancreatic cancer	0.000102	0.00093	CcSEcCtD
Captopril—Neutropenia—Epirubicin—pancreatic cancer	0.000102	0.000926	CcSEcCtD
Captopril—Rash—Sunitinib—pancreatic cancer	0.000102	0.000924	CcSEcCtD
Captopril—Dermatitis—Sunitinib—pancreatic cancer	0.000102	0.000923	CcSEcCtD
Captopril—Headache—Sunitinib—pancreatic cancer	0.000101	0.000918	CcSEcCtD
Captopril—Syncope—Docetaxel—pancreatic cancer	0.000101	0.000917	CcSEcCtD
Captopril—Pollakiuria—Epirubicin—pancreatic cancer	0.000101	0.000915	CcSEcCtD
Captopril—Body temperature increased—Fluorouracil—pancreatic cancer	0.000101	0.000914	CcSEcCtD
Captopril—Eosinophilia—Doxorubicin—pancreatic cancer	9.99e-05	0.000907	CcSEcCtD
Captopril—Palpitations—Docetaxel—pancreatic cancer	9.95e-05	0.000904	CcSEcCtD
Captopril—Photosensitivity reaction—Epirubicin—pancreatic cancer	9.95e-05	0.000904	CcSEcCtD
Captopril—Loss of consciousness—Docetaxel—pancreatic cancer	9.9e-05	0.000899	CcSEcCtD
Captopril—Pancreatitis—Doxorubicin—pancreatic cancer	9.89e-05	0.000898	CcSEcCtD
Captopril—Weight decreased—Epirubicin—pancreatic cancer	9.86e-05	0.000896	CcSEcCtD
Captopril—Cough—Docetaxel—pancreatic cancer	9.83e-05	0.000892	CcSEcCtD
Captopril—Angina pectoris—Doxorubicin—pancreatic cancer	9.83e-05	0.000892	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	9.64e-05	0.000875	CcSEcCtD
Captopril—Arthralgia—Docetaxel—pancreatic cancer	9.59e-05	0.000871	CcSEcCtD
Captopril—Chest pain—Docetaxel—pancreatic cancer	9.59e-05	0.000871	CcSEcCtD
Captopril—Myalgia—Docetaxel—pancreatic cancer	9.59e-05	0.000871	CcSEcCtD
Captopril—Nausea—Sunitinib—pancreatic cancer	9.59e-05	0.000871	CcSEcCtD
Captopril—Pancytopenia—Doxorubicin—pancreatic cancer	9.58e-05	0.00087	CcSEcCtD
Captopril—Renal failure—Epirubicin—pancreatic cancer	9.56e-05	0.000868	CcSEcCtD
Captopril—Asthenia—Irinotecan—pancreatic cancer	9.54e-05	0.000866	CcSEcCtD
Captopril—Stomatitis—Epirubicin—pancreatic cancer	9.47e-05	0.00086	CcSEcCtD
Captopril—Jaundice—Epirubicin—pancreatic cancer	9.47e-05	0.00086	CcSEcCtD
Captopril—Neutropenia—Doxorubicin—pancreatic cancer	9.43e-05	0.000857	CcSEcCtD
Captopril—Dry mouth—Docetaxel—pancreatic cancer	9.38e-05	0.000852	CcSEcCtD
Captopril—Pollakiuria—Doxorubicin—pancreatic cancer	9.32e-05	0.000846	CcSEcCtD
Captopril—Asthenia—Gemcitabine—pancreatic cancer	9.29e-05	0.000844	CcSEcCtD
Captopril—Confusional state—Docetaxel—pancreatic cancer	9.27e-05	0.000842	CcSEcCtD
Captopril—Photosensitivity reaction—Doxorubicin—pancreatic cancer	9.21e-05	0.000836	CcSEcCtD
Captopril—Anaphylactic shock—Docetaxel—pancreatic cancer	9.19e-05	0.000835	CcSEcCtD
Captopril—Pruritus—Gemcitabine—pancreatic cancer	9.16e-05	0.000832	CcSEcCtD
Captopril—Weight decreased—Doxorubicin—pancreatic cancer	9.13e-05	0.000829	CcSEcCtD
Captopril—Diarrhoea—Irinotecan—pancreatic cancer	9.1e-05	0.000826	CcSEcCtD
Captopril—Agranulocytosis—Epirubicin—pancreatic cancer	9.07e-05	0.000824	CcSEcCtD
Captopril—Shock—Docetaxel—pancreatic cancer	9.04e-05	0.000821	CcSEcCtD
Captopril—Pruritus—Fluorouracil—pancreatic cancer	9.01e-05	0.000818	CcSEcCtD
Captopril—Thrombocytopenia—Docetaxel—pancreatic cancer	9e-05	0.000817	CcSEcCtD
Captopril—Tachycardia—Docetaxel—pancreatic cancer	8.97e-05	0.000815	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	8.92e-05	0.00081	CcSEcCtD
Captopril—Diarrhoea—Gemcitabine—pancreatic cancer	8.86e-05	0.000805	CcSEcCtD
Captopril—Renal failure—Doxorubicin—pancreatic cancer	8.84e-05	0.000803	CcSEcCtD
Captopril—Dizziness—Irinotecan—pancreatic cancer	8.79e-05	0.000798	CcSEcCtD
Captopril—Jaundice—Doxorubicin—pancreatic cancer	8.77e-05	0.000796	CcSEcCtD
Captopril—Stomatitis—Doxorubicin—pancreatic cancer	8.77e-05	0.000796	CcSEcCtD
Captopril—Anorexia—Docetaxel—pancreatic cancer	8.76e-05	0.000796	CcSEcCtD
Captopril—Rhinitis—Epirubicin—pancreatic cancer	8.75e-05	0.000794	CcSEcCtD
Captopril—Hepatitis—Epirubicin—pancreatic cancer	8.73e-05	0.000792	CcSEcCtD
Captopril—Diarrhoea—Fluorouracil—pancreatic cancer	8.71e-05	0.000791	CcSEcCtD
Captopril—Pharyngitis—Epirubicin—pancreatic cancer	8.66e-05	0.000786	CcSEcCtD
Captopril—Hypotension—Docetaxel—pancreatic cancer	8.59e-05	0.00078	CcSEcCtD
Captopril—Vomiting—Irinotecan—pancreatic cancer	8.45e-05	0.000768	CcSEcCtD
Captopril—Dizziness—Fluorouracil—pancreatic cancer	8.42e-05	0.000765	CcSEcCtD
Captopril—Agranulocytosis—Doxorubicin—pancreatic cancer	8.39e-05	0.000762	CcSEcCtD
Captopril—Rash—Irinotecan—pancreatic cancer	8.38e-05	0.000761	CcSEcCtD
Captopril—Dermatitis—Irinotecan—pancreatic cancer	8.38e-05	0.000761	CcSEcCtD
Captopril—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	8.37e-05	0.00076	CcSEcCtD
Captopril—Headache—Irinotecan—pancreatic cancer	8.33e-05	0.000756	CcSEcCtD
Captopril—Insomnia—Docetaxel—pancreatic cancer	8.31e-05	0.000755	CcSEcCtD
Captopril—Paraesthesia—Docetaxel—pancreatic cancer	8.25e-05	0.00075	CcSEcCtD
Captopril—Erythema multiforme—Epirubicin—pancreatic cancer	8.25e-05	0.000749	CcSEcCtD
Captopril—Vomiting—Gemcitabine—pancreatic cancer	8.23e-05	0.000748	CcSEcCtD
Captopril—Dyspnoea—Docetaxel—pancreatic cancer	8.19e-05	0.000744	CcSEcCtD
Captopril—Somnolence—Docetaxel—pancreatic cancer	8.17e-05	0.000742	CcSEcCtD
Captopril—Rash—Gemcitabine—pancreatic cancer	8.17e-05	0.000742	CcSEcCtD
Captopril—Dermatitis—Gemcitabine—pancreatic cancer	8.16e-05	0.000741	CcSEcCtD
Captopril—Headache—Gemcitabine—pancreatic cancer	8.11e-05	0.000737	CcSEcCtD
Captopril—Flushing—Epirubicin—pancreatic cancer	8.1e-05	0.000735	CcSEcCtD
Captopril—Vomiting—Fluorouracil—pancreatic cancer	8.1e-05	0.000735	CcSEcCtD
Captopril—Rhinitis—Doxorubicin—pancreatic cancer	8.09e-05	0.000735	CcSEcCtD
Captopril—Dyspepsia—Docetaxel—pancreatic cancer	8.09e-05	0.000735	CcSEcCtD
Captopril—Hepatitis—Doxorubicin—pancreatic cancer	8.07e-05	0.000733	CcSEcCtD
Captopril—Rash—Fluorouracil—pancreatic cancer	8.03e-05	0.000729	CcSEcCtD
Captopril—Dermatitis—Fluorouracil—pancreatic cancer	8.02e-05	0.000729	CcSEcCtD
Captopril—Pharyngitis—Doxorubicin—pancreatic cancer	8.01e-05	0.000728	CcSEcCtD
Captopril—Decreased appetite—Docetaxel—pancreatic cancer	7.99e-05	0.000726	CcSEcCtD
Captopril—Headache—Fluorouracil—pancreatic cancer	7.98e-05	0.000724	CcSEcCtD
Captopril—Fatigue—Docetaxel—pancreatic cancer	7.92e-05	0.00072	CcSEcCtD
Captopril—Nausea—Irinotecan—pancreatic cancer	7.9e-05	0.000717	CcSEcCtD
Captopril—Constipation—Docetaxel—pancreatic cancer	7.86e-05	0.000714	CcSEcCtD
Captopril—Alopecia—Epirubicin—pancreatic cancer	7.71e-05	0.0007	CcSEcCtD
Captopril—Nausea—Gemcitabine—pancreatic cancer	7.69e-05	0.000699	CcSEcCtD
Captopril—Erythema multiforme—Doxorubicin—pancreatic cancer	7.63e-05	0.000693	CcSEcCtD
Captopril—Feeling abnormal—Docetaxel—pancreatic cancer	7.57e-05	0.000688	CcSEcCtD
Captopril—Nausea—Fluorouracil—pancreatic cancer	7.56e-05	0.000687	CcSEcCtD
Captopril—Gastrointestinal pain—Docetaxel—pancreatic cancer	7.52e-05	0.000683	CcSEcCtD
Captopril—Flushing—Doxorubicin—pancreatic cancer	7.49e-05	0.00068	CcSEcCtD
Captopril—Tension—Epirubicin—pancreatic cancer	7.45e-05	0.000677	CcSEcCtD
Captopril—Dysgeusia—Epirubicin—pancreatic cancer	7.44e-05	0.000676	CcSEcCtD
Captopril—Nervousness—Epirubicin—pancreatic cancer	7.38e-05	0.00067	CcSEcCtD
Captopril—Abdominal pain—Docetaxel—pancreatic cancer	7.27e-05	0.00066	CcSEcCtD
Captopril—Body temperature increased—Docetaxel—pancreatic cancer	7.27e-05	0.00066	CcSEcCtD
Captopril—Vision blurred—Epirubicin—pancreatic cancer	7.16e-05	0.00065	CcSEcCtD
Captopril—Alopecia—Doxorubicin—pancreatic cancer	7.13e-05	0.000648	CcSEcCtD
Captopril—Ill-defined disorder—Epirubicin—pancreatic cancer	7.05e-05	0.00064	CcSEcCtD
Captopril—Anaemia—Epirubicin—pancreatic cancer	7.02e-05	0.000638	CcSEcCtD
Captopril—Tension—Doxorubicin—pancreatic cancer	6.9e-05	0.000626	CcSEcCtD
Captopril—Dysgeusia—Doxorubicin—pancreatic cancer	6.88e-05	0.000625	CcSEcCtD
Captopril—Malaise—Epirubicin—pancreatic cancer	6.85e-05	0.000622	CcSEcCtD
Captopril—Nervousness—Doxorubicin—pancreatic cancer	6.83e-05	0.00062	CcSEcCtD
Captopril—Syncope—Epirubicin—pancreatic cancer	6.81e-05	0.000619	CcSEcCtD
Captopril—Palpitations—Epirubicin—pancreatic cancer	6.71e-05	0.00061	CcSEcCtD
Captopril—Loss of consciousness—Epirubicin—pancreatic cancer	6.68e-05	0.000606	CcSEcCtD
Captopril—Cough—Epirubicin—pancreatic cancer	6.63e-05	0.000602	CcSEcCtD
Captopril—Vision blurred—Doxorubicin—pancreatic cancer	6.62e-05	0.000602	CcSEcCtD
Captopril—Asthenia—Docetaxel—pancreatic cancer	6.59e-05	0.000599	CcSEcCtD
Captopril—Ill-defined disorder—Doxorubicin—pancreatic cancer	6.52e-05	0.000592	CcSEcCtD
Captopril—Pruritus—Docetaxel—pancreatic cancer	6.5e-05	0.000591	CcSEcCtD
Captopril—Anaemia—Doxorubicin—pancreatic cancer	6.5e-05	0.00059	CcSEcCtD
Captopril—Arthralgia—Epirubicin—pancreatic cancer	6.47e-05	0.000587	CcSEcCtD
Captopril—Chest pain—Epirubicin—pancreatic cancer	6.47e-05	0.000587	CcSEcCtD
Captopril—Myalgia—Epirubicin—pancreatic cancer	6.47e-05	0.000587	CcSEcCtD
Captopril—Discomfort—Epirubicin—pancreatic cancer	6.39e-05	0.00058	CcSEcCtD
Captopril—Malaise—Doxorubicin—pancreatic cancer	6.34e-05	0.000576	CcSEcCtD
Captopril—Dry mouth—Epirubicin—pancreatic cancer	6.32e-05	0.000574	CcSEcCtD
Captopril—Syncope—Doxorubicin—pancreatic cancer	6.3e-05	0.000572	CcSEcCtD
Captopril—Diarrhoea—Docetaxel—pancreatic cancer	6.29e-05	0.000571	CcSEcCtD
Captopril—Confusional state—Epirubicin—pancreatic cancer	6.25e-05	0.000568	CcSEcCtD
Captopril—Palpitations—Doxorubicin—pancreatic cancer	6.21e-05	0.000564	CcSEcCtD
Captopril—Anaphylactic shock—Epirubicin—pancreatic cancer	6.2e-05	0.000563	CcSEcCtD
Captopril—Loss of consciousness—Doxorubicin—pancreatic cancer	6.18e-05	0.000561	CcSEcCtD
Captopril—Cough—Doxorubicin—pancreatic cancer	6.13e-05	0.000557	CcSEcCtD
Captopril—Shock—Epirubicin—pancreatic cancer	6.1e-05	0.000554	CcSEcCtD
Captopril—Dizziness—Docetaxel—pancreatic cancer	6.08e-05	0.000552	CcSEcCtD
Captopril—Thrombocytopenia—Epirubicin—pancreatic cancer	6.07e-05	0.000551	CcSEcCtD
Captopril—Tachycardia—Epirubicin—pancreatic cancer	6.05e-05	0.000549	CcSEcCtD
Captopril—Arthralgia—Doxorubicin—pancreatic cancer	5.98e-05	0.000543	CcSEcCtD
Captopril—Myalgia—Doxorubicin—pancreatic cancer	5.98e-05	0.000543	CcSEcCtD
Captopril—Chest pain—Doxorubicin—pancreatic cancer	5.98e-05	0.000543	CcSEcCtD
Captopril—Discomfort—Doxorubicin—pancreatic cancer	5.91e-05	0.000537	CcSEcCtD
Captopril—Anorexia—Epirubicin—pancreatic cancer	5.91e-05	0.000537	CcSEcCtD
Captopril—Dry mouth—Doxorubicin—pancreatic cancer	5.85e-05	0.000531	CcSEcCtD
Captopril—Vomiting—Docetaxel—pancreatic cancer	5.84e-05	0.000531	CcSEcCtD
Captopril—Rash—Docetaxel—pancreatic cancer	5.8e-05	0.000526	CcSEcCtD
Captopril—Hypotension—Epirubicin—pancreatic cancer	5.79e-05	0.000526	CcSEcCtD
Captopril—Dermatitis—Docetaxel—pancreatic cancer	5.79e-05	0.000526	CcSEcCtD
Captopril—Confusional state—Doxorubicin—pancreatic cancer	5.78e-05	0.000525	CcSEcCtD
Captopril—Headache—Docetaxel—pancreatic cancer	5.76e-05	0.000523	CcSEcCtD
Captopril—Anaphylactic shock—Doxorubicin—pancreatic cancer	5.74e-05	0.000521	CcSEcCtD
Captopril—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	5.65e-05	0.000513	CcSEcCtD
Captopril—Shock—Doxorubicin—pancreatic cancer	5.64e-05	0.000513	CcSEcCtD
Captopril—Thrombocytopenia—Doxorubicin—pancreatic cancer	5.62e-05	0.00051	CcSEcCtD
Captopril—Insomnia—Epirubicin—pancreatic cancer	5.61e-05	0.000509	CcSEcCtD
Captopril—Tachycardia—Doxorubicin—pancreatic cancer	5.6e-05	0.000508	CcSEcCtD
Captopril—Paraesthesia—Epirubicin—pancreatic cancer	5.57e-05	0.000506	CcSEcCtD
Captopril—Dyspnoea—Epirubicin—pancreatic cancer	5.53e-05	0.000502	CcSEcCtD
Captopril—Somnolence—Epirubicin—pancreatic cancer	5.51e-05	0.000501	CcSEcCtD
Captopril—Anorexia—Doxorubicin—pancreatic cancer	5.47e-05	0.000497	CcSEcCtD
Captopril—Nausea—Docetaxel—pancreatic cancer	5.46e-05	0.000496	CcSEcCtD
Captopril—Dyspepsia—Epirubicin—pancreatic cancer	5.46e-05	0.000496	CcSEcCtD
Captopril—Decreased appetite—Epirubicin—pancreatic cancer	5.39e-05	0.000489	CcSEcCtD
Captopril—Hypotension—Doxorubicin—pancreatic cancer	5.36e-05	0.000487	CcSEcCtD
Captopril—Fatigue—Epirubicin—pancreatic cancer	5.34e-05	0.000485	CcSEcCtD
Captopril—Constipation—Epirubicin—pancreatic cancer	5.3e-05	0.000481	CcSEcCtD
Captopril—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	5.23e-05	0.000475	CcSEcCtD
Captopril—Insomnia—Doxorubicin—pancreatic cancer	5.19e-05	0.000471	CcSEcCtD
Captopril—Paraesthesia—Doxorubicin—pancreatic cancer	5.15e-05	0.000468	CcSEcCtD
Captopril—Dyspnoea—Doxorubicin—pancreatic cancer	5.11e-05	0.000464	CcSEcCtD
Captopril—Feeling abnormal—Epirubicin—pancreatic cancer	5.11e-05	0.000464	CcSEcCtD
Captopril—Somnolence—Doxorubicin—pancreatic cancer	5.1e-05	0.000463	CcSEcCtD
Captopril—Gastrointestinal pain—Epirubicin—pancreatic cancer	5.07e-05	0.00046	CcSEcCtD
Captopril—Dyspepsia—Doxorubicin—pancreatic cancer	5.05e-05	0.000459	CcSEcCtD
Captopril—Decreased appetite—Doxorubicin—pancreatic cancer	4.99e-05	0.000453	CcSEcCtD
Captopril—Fatigue—Doxorubicin—pancreatic cancer	4.95e-05	0.000449	CcSEcCtD
Captopril—Constipation—Doxorubicin—pancreatic cancer	4.91e-05	0.000445	CcSEcCtD
Captopril—Abdominal pain—Epirubicin—pancreatic cancer	4.9e-05	0.000445	CcSEcCtD
Captopril—Body temperature increased—Epirubicin—pancreatic cancer	4.9e-05	0.000445	CcSEcCtD
Captopril—Feeling abnormal—Doxorubicin—pancreatic cancer	4.73e-05	0.000429	CcSEcCtD
Captopril—Gastrointestinal pain—Doxorubicin—pancreatic cancer	4.69e-05	0.000426	CcSEcCtD
Captopril—Body temperature increased—Doxorubicin—pancreatic cancer	4.53e-05	0.000412	CcSEcCtD
Captopril—Abdominal pain—Doxorubicin—pancreatic cancer	4.53e-05	0.000412	CcSEcCtD
Captopril—Asthenia—Epirubicin—pancreatic cancer	4.45e-05	0.000404	CcSEcCtD
Captopril—Pruritus—Epirubicin—pancreatic cancer	4.39e-05	0.000398	CcSEcCtD
Captopril—Diarrhoea—Epirubicin—pancreatic cancer	4.24e-05	0.000385	CcSEcCtD
Captopril—Asthenia—Doxorubicin—pancreatic cancer	4.12e-05	0.000374	CcSEcCtD
Captopril—Dizziness—Epirubicin—pancreatic cancer	4.1e-05	0.000372	CcSEcCtD
Captopril—Pruritus—Doxorubicin—pancreatic cancer	4.06e-05	0.000369	CcSEcCtD
Captopril—Vomiting—Epirubicin—pancreatic cancer	3.94e-05	0.000358	CcSEcCtD
Captopril—Diarrhoea—Doxorubicin—pancreatic cancer	3.92e-05	0.000356	CcSEcCtD
Captopril—Rash—Epirubicin—pancreatic cancer	3.91e-05	0.000355	CcSEcCtD
Captopril—Dermatitis—Epirubicin—pancreatic cancer	3.91e-05	0.000355	CcSEcCtD
Captopril—Headache—Epirubicin—pancreatic cancer	3.88e-05	0.000353	CcSEcCtD
Captopril—Dizziness—Doxorubicin—pancreatic cancer	3.79e-05	0.000344	CcSEcCtD
Captopril—Nausea—Epirubicin—pancreatic cancer	3.68e-05	0.000334	CcSEcCtD
Captopril—Vomiting—Doxorubicin—pancreatic cancer	3.65e-05	0.000331	CcSEcCtD
Captopril—Rash—Doxorubicin—pancreatic cancer	3.62e-05	0.000328	CcSEcCtD
Captopril—Dermatitis—Doxorubicin—pancreatic cancer	3.61e-05	0.000328	CcSEcCtD
Captopril—Headache—Doxorubicin—pancreatic cancer	3.59e-05	0.000326	CcSEcCtD
Captopril—Nausea—Doxorubicin—pancreatic cancer	3.41e-05	0.000309	CcSEcCtD
Captopril—MMP9—Developmental Biology—CTNNB1—pancreatic cancer	2.15e-05	0.000241	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SCT—pancreatic cancer	2.13e-05	0.000238	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HEY1—pancreatic cancer	2.13e-05	0.000238	CbGpPWpGaD
Captopril—F2—Hemostasis—PIK3CD—pancreatic cancer	2.11e-05	0.000236	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—HRAS—pancreatic cancer	2.09e-05	0.000234	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	2.06e-05	0.00023	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCK—pancreatic cancer	2.03e-05	0.000227	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	2.03e-05	0.000226	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SST—pancreatic cancer	1.99e-05	0.000223	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—TNF—pancreatic cancer	1.98e-05	0.000221	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CNR2—pancreatic cancer	1.98e-05	0.000221	CbGpPWpGaD
Captopril—F2—Signaling Pathways—GLP1R—pancreatic cancer	1.98e-05	0.000221	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—CXCL8—pancreatic cancer	1.98e-05	0.000221	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—JAG1—pancreatic cancer	1.95e-05	0.000218	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—SRC—pancreatic cancer	1.95e-05	0.000218	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCKAR—pancreatic cancer	1.95e-05	0.000218	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NOTCH3—pancreatic cancer	1.94e-05	0.000217	CbGpPWpGaD
Captopril—MMP9—Axon guidance—HRAS—pancreatic cancer	1.92e-05	0.000215	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—VEGFA—pancreatic cancer	1.9e-05	0.000212	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—TNF—pancreatic cancer	1.89e-05	0.000211	CbGpPWpGaD
Captopril—F2—Signaling Pathways—JAG2—pancreatic cancer	1.89e-05	0.000211	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	1.88e-05	0.00021	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—STAT3—pancreatic cancer	1.88e-05	0.00021	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—NRAS—pancreatic cancer	1.87e-05	0.000209	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	1.87e-05	0.000209	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MEN1—pancreatic cancer	1.86e-05	0.000208	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—PIK3CG—pancreatic cancer	1.85e-05	0.000207	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—AKT1—pancreatic cancer	1.85e-05	0.000206	CbGpPWpGaD
Captopril—F2—Hemostasis—PIK3CB—pancreatic cancer	1.84e-05	0.000206	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CNR1—pancreatic cancer	1.84e-05	0.000206	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—EGF—pancreatic cancer	1.83e-05	0.000204	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	1.8e-05	0.000201	CbGpPWpGaD
Captopril—LTA4H—Metabolism—AKT1—pancreatic cancer	1.78e-05	0.000199	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	1.78e-05	0.000199	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—GCG—pancreatic cancer	1.78e-05	0.000199	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SHH—pancreatic cancer	1.78e-05	0.000198	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NOTCH4—pancreatic cancer	1.76e-05	0.000197	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IAPP—pancreatic cancer	1.75e-05	0.000196	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—TGFB1—pancreatic cancer	1.74e-05	0.000195	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—EGFR—pancreatic cancer	1.71e-05	0.000191	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AGTR1—pancreatic cancer	1.7e-05	0.000189	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PTHLH—pancreatic cancer	1.68e-05	0.000188	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PTCH1—pancreatic cancer	1.68e-05	0.000188	CbGpPWpGaD
Captopril—ALB—Hemostasis—CD44—pancreatic cancer	1.67e-05	0.000187	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—MMP2—pancreatic cancer	1.67e-05	0.000187	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—STK11—pancreatic cancer	1.67e-05	0.000187	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	1.64e-05	0.000183	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	1.63e-05	0.000182	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—TNF—pancreatic cancer	1.63e-05	0.000182	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—PIK3CD—pancreatic cancer	1.63e-05	0.000182	CbGpPWpGaD
Captopril—ALB—Hemostasis—IFNA1—pancreatic cancer	1.62e-05	0.000181	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—KRAS—pancreatic cancer	1.61e-05	0.00018	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SST—pancreatic cancer	1.54e-05	0.000172	CbGpPWpGaD
Captopril—ALB—Metabolism—PRSS1—pancreatic cancer	1.54e-05	0.000172	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—PIK3CG—pancreatic cancer	1.52e-05	0.00017	CbGpPWpGaD
Captopril—ALB—Hemostasis—IFNA2—pancreatic cancer	1.51e-05	0.000169	CbGpPWpGaD
Captopril—F2—Signaling Pathways—JAG1—pancreatic cancer	1.51e-05	0.000168	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NOTCH3—pancreatic cancer	1.5e-05	0.000168	CbGpPWpGaD
Captopril—F2—Hemostasis—SRC—pancreatic cancer	1.48e-05	0.000165	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SMAD4—pancreatic cancer	1.46e-05	0.000164	CbGpPWpGaD
Captopril—F2—Hemostasis—VEGFA—pancreatic cancer	1.44e-05	0.000161	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HES1—pancreatic cancer	1.43e-05	0.00016	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CNR1—pancreatic cancer	1.42e-05	0.000159	CbGpPWpGaD
Captopril—F2—Hemostasis—NRAS—pancreatic cancer	1.42e-05	0.000159	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	1.42e-05	0.000158	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—CXCL8—pancreatic cancer	1.39e-05	0.000156	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	1.38e-05	0.000154	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PIK3CG—pancreatic cancer	1.38e-05	0.000154	CbGpPWpGaD
Captopril—F2—Signaling Pathways—GCG—pancreatic cancer	1.37e-05	0.000153	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—HRAS—pancreatic cancer	1.37e-05	0.000153	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PRSS1—pancreatic cancer	1.35e-05	0.000151	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.33e-05	0.000149	CbGpPWpGaD
Captopril—ALB—Metabolism—ARG2—pancreatic cancer	1.33e-05	0.000149	CbGpPWpGaD
Captopril—F2—Hemostasis—TGFB1—pancreatic cancer	1.32e-05	0.000147	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AGTR1—pancreatic cancer	1.31e-05	0.000146	CbGpPWpGaD
Captopril—F2—Signaling Pathways—STK11—pancreatic cancer	1.29e-05	0.000144	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—CTNNB1—pancreatic cancer	1.28e-05	0.000143	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	1.28e-05	0.000143	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PRSS1—pancreatic cancer	1.27e-05	0.000142	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TERT—pancreatic cancer	1.25e-05	0.00014	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	1.25e-05	0.00014	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	1.24e-05	0.000138	CbGpPWpGaD
Captopril—F2—Hemostasis—KRAS—pancreatic cancer	1.22e-05	0.000136	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PIK3CD—pancreatic cancer	1.21e-05	0.000135	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—AKT1—pancreatic cancer	1.21e-05	0.000135	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	1.21e-05	0.000135	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HIF1A—pancreatic cancer	1.2e-05	0.000134	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TSC2—pancreatic cancer	1.19e-05	0.000133	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—APOE—pancreatic cancer	1.17e-05	0.000131	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ARG2—pancreatic cancer	1.17e-05	0.000131	CbGpPWpGaD
Captopril—ALB—Metabolism—TYMP—pancreatic cancer	1.17e-05	0.00013	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.16e-05	0.00013	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—KDR—pancreatic cancer	1.15e-05	0.000128	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	1.14e-05	0.000127	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SMAD4—pancreatic cancer	1.13e-05	0.000126	CbGpPWpGaD
Captopril—F2—Hemostasis—PIK3CA—pancreatic cancer	1.12e-05	0.000125	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	1.12e-05	0.000125	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CXCL8—pancreatic cancer	1.12e-05	0.000125	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	1.11e-05	0.000124	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HES1—pancreatic cancer	1.1e-05	0.000123	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ARG2—pancreatic cancer	1.1e-05	0.000123	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NFKBIA—pancreatic cancer	1.09e-05	0.000122	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	1.09e-05	0.000122	CbGpPWpGaD
Captopril—F2—Hemostasis—TP53—pancreatic cancer	1.09e-05	0.000121	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NOTCH1—pancreatic cancer	1.08e-05	0.000121	CbGpPWpGaD
Captopril—ALB—Hemostasis—PLAU—pancreatic cancer	1.07e-05	0.00012	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PIK3CB—pancreatic cancer	1.06e-05	0.000118	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PIK3CG—pancreatic cancer	1.05e-05	0.000118	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—EGF—pancreatic cancer	1.04e-05	0.000117	CbGpPWpGaD
Captopril—F2—Hemostasis—HRAS—pancreatic cancer	1.04e-05	0.000116	CbGpPWpGaD
Captopril—ABCB1—Metabolism—TYMP—pancreatic cancer	1.02e-05	0.000114	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CXCL8—pancreatic cancer	1.02e-05	0.000113	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	1.02e-05	0.000113	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	1e-05	0.000112	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	1e-05	0.000112	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	9.8e-06	0.00011	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TERT—pancreatic cancer	9.67e-06	0.000108	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—TYMP—pancreatic cancer	9.62e-06	0.000108	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	9.62e-06	0.000107	CbGpPWpGaD
Captopril—ALB—Hemostasis—PIK3CG—pancreatic cancer	9.53e-06	0.000107	CbGpPWpGaD
Captopril—ALB—Hemostasis—EGF—pancreatic cancer	9.42e-06	0.000105	CbGpPWpGaD
Captopril—ALB—Metabolism—GLP1R—pancreatic cancer	9.39e-06	0.000105	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	9.33e-06	0.000104	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PIK3CD—pancreatic cancer	9.27e-06	0.000104	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	9.26e-06	0.000103	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HIF1A—pancreatic cancer	9.24e-06	0.000103	CbGpPWpGaD
Captopril—ALB—Metabolism—DPYD—pancreatic cancer	9.24e-06	0.000103	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TSC2—pancreatic cancer	9.22e-06	0.000103	CbGpPWpGaD
Captopril—F2—Hemostasis—AKT1—pancreatic cancer	9.17e-06	0.000102	CbGpPWpGaD
Captopril—F2—Signaling Pathways—APOE—pancreatic cancer	9.02e-06	0.000101	CbGpPWpGaD
Captopril—F2—Signaling Pathways—KDR—pancreatic cancer	8.84e-06	9.88e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—SLC2A2—pancreatic cancer	8.77e-06	9.8e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	8.68e-06	9.7e-05	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	8.64e-06	9.65e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	8.51e-06	9.5e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NFKBIA—pancreatic cancer	8.41e-06	9.4e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—PIK3CD—pancreatic cancer	8.38e-06	9.36e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	8.38e-06	9.36e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NOTCH1—pancreatic cancer	8.33e-06	9.31e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GLP1R—pancreatic cancer	8.23e-06	9.2e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	8.23e-06	9.2e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PIK3CG—pancreatic cancer	8.14e-06	9.1e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—NRAS—pancreatic cancer	8.14e-06	9.1e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—DPYD—pancreatic cancer	8.1e-06	9.05e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PIK3CB—pancreatic cancer	8.08e-06	9.03e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—EGF—pancreatic cancer	8.05e-06	9e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CXCL8—pancreatic cancer	7.77e-06	8.68e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GLP1R—pancreatic cancer	7.76e-06	8.67e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SLC2A2—pancreatic cancer	7.68e-06	8.59e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—DPYD—pancreatic cancer	7.63e-06	8.53e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	7.63e-06	8.53e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CASP3—pancreatic cancer	7.43e-06	8.31e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—EGFR—pancreatic cancer	7.42e-06	8.29e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—PIK3CB—pancreatic cancer	7.3e-06	8.16e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	7.24e-06	8.09e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCND1—pancreatic cancer	7.24e-06	8.09e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CTNNB1—pancreatic cancer	7.17e-06	8.01e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PIK3CD—pancreatic cancer	7.16e-06	8e-05	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—PIK3CA—pancreatic cancer	7.09e-06	7.92e-05	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	7.06e-06	7.89e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—KRAS—pancreatic cancer	7.01e-06	7.83e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PTEN—pancreatic cancer	6.98e-06	7.81e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	6.95e-06	7.76e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CD44—pancreatic cancer	6.79e-06	7.59e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.65e-06	7.43e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.59e-06	7.36e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GCG—pancreatic cancer	6.51e-06	7.28e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SRC—pancreatic cancer	6.48e-06	7.24e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PIK3CA—pancreatic cancer	6.44e-06	7.2e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—VEGFA—pancreatic cancer	6.31e-06	7.05e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—STAT3—pancreatic cancer	6.25e-06	6.98e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PIK3CB—pancreatic cancer	6.24e-06	6.97e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NRAS—pancreatic cancer	6.23e-06	6.96e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—STK11—pancreatic cancer	6.12e-06	6.84e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CXCL8—pancreatic cancer	6e-06	6.7e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—HRAS—pancreatic cancer	5.96e-06	6.66e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CD44—pancreatic cancer	5.95e-06	6.65e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—SRC—pancreatic cancer	5.85e-06	6.54e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MYC—pancreatic cancer	5.8e-06	6.49e-05	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—AKT1—pancreatic cancer	5.79e-06	6.47e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TGFB1—pancreatic cancer	5.79e-06	6.47e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.75e-06	6.42e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CASP3—pancreatic cancer	5.74e-06	6.41e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GCG—pancreatic cancer	5.7e-06	6.37e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—VEGFA—pancreatic cancer	5.7e-06	6.37e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—EGFR—pancreatic cancer	5.68e-06	6.34e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—NRAS—pancreatic cancer	5.63e-06	6.29e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CD44—pancreatic cancer	5.61e-06	6.27e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCND1—pancreatic cancer	5.59e-06	6.24e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CTNNB1—pancreatic cancer	5.53e-06	6.18e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MMP9—pancreatic cancer	5.42e-06	6.06e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PTEN—pancreatic cancer	5.39e-06	6.03e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GCG—pancreatic cancer	5.38e-06	6.01e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—STK11—pancreatic cancer	5.36e-06	5.99e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—KRAS—pancreatic cancer	5.36e-06	5.99e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—TYMS—pancreatic cancer	5.27e-06	5.88e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—AKT1—pancreatic cancer	5.26e-06	5.88e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—TGFB1—pancreatic cancer	5.23e-06	5.85e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—STK11—pancreatic cancer	5.05e-06	5.65e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SRC—pancreatic cancer	5e-06	5.59e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PIK3CA—pancreatic cancer	4.93e-06	5.51e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—VEGFA—pancreatic cancer	4.87e-06	5.44e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—KRAS—pancreatic cancer	4.85e-06	5.42e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—STAT3—pancreatic cancer	4.82e-06	5.39e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NRAS—pancreatic cancer	4.81e-06	5.38e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TP53—pancreatic cancer	4.77e-06	5.33e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—TYMS—pancreatic cancer	4.61e-06	5.16e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HRAS—pancreatic cancer	4.56e-06	5.09e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MYC—pancreatic cancer	4.48e-06	5.01e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TGFB1—pancreatic cancer	4.47e-06	5e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—PIK3CA—pancreatic cancer	4.45e-06	4.98e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—EGFR—pancreatic cancer	4.38e-06	4.9e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—TYMS—pancreatic cancer	4.35e-06	4.86e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—TP53—pancreatic cancer	4.31e-06	4.81e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—APOE—pancreatic cancer	4.28e-06	4.79e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—KRAS—pancreatic cancer	4.14e-06	4.63e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—HRAS—pancreatic cancer	4.12e-06	4.6e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.05e-06	4.53e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AKT1—pancreatic cancer	4.03e-06	4.5e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PIK3CG—pancreatic cancer	3.86e-06	4.32e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PIK3CA—pancreatic cancer	3.8e-06	4.25e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—APOE—pancreatic cancer	3.75e-06	4.19e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PPARG—pancreatic cancer	3.73e-06	4.17e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TP53—pancreatic cancer	3.68e-06	4.11e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—AKT1—pancreatic cancer	3.64e-06	4.06e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—APOE—pancreatic cancer	3.54e-06	3.95e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HRAS—pancreatic cancer	3.52e-06	3.93e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PIK3CD—pancreatic cancer	3.4e-06	3.8e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PIK3CG—pancreatic cancer	3.39e-06	3.78e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PPARG—pancreatic cancer	3.27e-06	3.65e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	3.19e-06	3.57e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AKT1—pancreatic cancer	3.11e-06	3.47e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PPARG—pancreatic cancer	3.08e-06	3.44e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PIK3CD—pancreatic cancer	2.98e-06	3.33e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PIK3CB—pancreatic cancer	2.96e-06	3.31e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PTGS2—pancreatic cancer	2.93e-06	3.28e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	2.81e-06	3.13e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PIK3CB—pancreatic cancer	2.59e-06	2.9e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTGS2—pancreatic cancer	2.57e-06	2.87e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PTEN—pancreatic cancer	2.56e-06	2.86e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	2.45e-06	2.73e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTGS2—pancreatic cancer	2.42e-06	2.71e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTEN—pancreatic cancer	2.24e-06	2.51e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTEN—pancreatic cancer	2.11e-06	2.36e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PIK3CA—pancreatic cancer	1.81e-06	2.02e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PIK3CA—pancreatic cancer	1.58e-06	1.77e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.49e-06	1.67e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—AKT1—pancreatic cancer	1.47e-06	1.65e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—AKT1—pancreatic cancer	1.29e-06	1.44e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.22e-06	1.36e-05	CbGpPWpGaD
